Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients

Table 1 Inclusion criteria

Age:	≥18years
WHO performance status:	≤ 2
Histologically-proven of primary cancer disease
M1 stage with primary cancer site radically treated with complete response/resection or stable.
No other site of disease in progression (a maximum of 3 lymph node sites of disease to treat)
Diameter:	<5 cm
Abdomen/pelvic site
No previous surgery or RT in the region to treat
Informed consent.

ISSN: 1748-717X